Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis
Authors
Keywords
-
Journal
AAPS PHARMSCITECH
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-11
DOI
10.1208/s12249-021-02146-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Update on TB Vaccine Pipeline
- (2020) Carlos Martin et al. Applied Sciences-Basel
- Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity
- (2020) Yaping Mai et al. CELLULAR IMMUNOLOGY
- Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers
- (2020) Jing Zhao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Recent progress in the design of DNA vaccines against tuberculosis
- (2020) Youssof Sefidi-Heris et al. DRUG DISCOVERY TODAY
- An Overview of the Development of New Vaccines for Tuberculosis
- (2020) E. Whitlow et al. Vaccines
- Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
- (2019) Karin Dijkman et al. NATURE MEDICINE
- Tuberculosis Vaccine Development: Progress in Clinical Evaluation
- (2019) Suraj B. Sable et al. CLINICAL MICROBIOLOGY REVIEWS
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concrete action now: UN High-Level Meeting on Tuberculosis
- (2018) Nick Herbert et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
- (2018) Adam Penn-Nicholson et al. Lancet Respiratory Medicine
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
- (2018) Rhea N. Coler et al. npj Vaccines
- The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1
- (2018) Mona Kabiri et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles
- (2018) Mona Kabiri et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
- (2017) Farzad Khademi et al. Expert Review of Vaccines
- MTBVAC from discovery to clinical trials in tuberculosis-endemic countries
- (2017) Dessislava Marinova et al. Expert Review of Vaccines
- Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles
- (2017) Guangsheng Du et al. JOURNAL OF CONTROLLED RELEASE
- A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice
- (2017) Mushtaq Ahmed et al. VACCINE
- IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection
- (2017) Shengfeng Hu et al. EBioMedicine
- TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulates strong cellular immunity in mice
- (2016) Yousef Amini et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
- (2016) Man Li et al. JOURNAL OF CONTROLLED RELEASE
- Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
- (2016) J S Woodworth et al. Mucosal Immunology
- The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis
- (2016) Monalisa M. Trentini et al. Frontiers in Microbiology
- On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines
- (2016) Sergio Arregui et al. PeerJ
- B cells and antibodies in the defense againstMycobacterium tuberculosisinfection
- (2015) Jacqueline M. Achkar et al. IMMUNOLOGICAL REVIEWS
- T cells and adaptive immunity toMycobacterium tuberculosisin humans
- (2015) Luke D. Jasenosky et al. IMMUNOLOGICAL REVIEWS
- Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge
- (2015) L Monin et al. Mucosal Immunology
- Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis
- (2015) Deepak Kaushal et al. Nature Communications
- Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice
- (2015) Hongxia Niu et al. PLoS One
- Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants
- (2014) Solmaz Dehghan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis
- (2014) S. Bertholet et al. JOURNAL OF IMMUNOLOGY
- A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
- (2014) Adeliane Castro da Costa et al. PLoS One
- Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics
- (2014) N. P. H. Knudsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pro- and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis
- (2014) Marilena Paola Etna et al. SEMINARS IN IMMUNOLOGY
- Novel Vaccination Strategies against Tuberculosis
- (2014) P. Andersen et al. Cold Spring Harbor Perspectives in Medicine
- Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
- (2014) Stefan H E Kaufmann et al. Lancet Respiratory Medicine
- Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery
- (2013) Yichao Wang et al. AAPS PHARMSCITECH
- Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunization
- (2013) S. Dehghan et al. ARCHIVES OF PHARMACAL RESEARCH
- Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
- (2013) Dilip Pawar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice
- (2013) Qi Xin et al. PLoS One
- ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination
- (2013) Truc Hoang et al. PLoS One
- Prime–Boost with Mycobacterium smegmatis Recombinant Vaccine Improves Protection in Mice Infected with Mycobacterium tuberculosis
- (2013) Ana Paula Junqueira-Kipnis et al. PLoS One
- A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
- (2013) F. Smaill et al. Science Translational Medicine
- Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
- (2012) Stacey L. Demento et al. BIOMATERIALS
- Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?
- (2011) Smitha J. Sasindran et al. Frontiers in Microbiology
- IL-17 and Th17 cells in tuberculosis
- (2010) Egídio Torrado et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection withMycobacterium tuberculosis
- (2010) Andrea Cruz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen
- (2010) Bram Slütter et al. VACCINE
- Vaccination Route That Induces Transforming Growth Factor Production Fails To Elicit Protective Immunity against Leishmania donovani Infection
- (2009) S. Bhowmick et al. INFECTION AND IMMUNITY
- IL-17–producing T cells in lung immunity and inflammation
- (2009) Chiara Nembrini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations
- (2009) Suzanne M. Bal et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticles for nasal vaccination
- (2008) Noemi Csaba et al. ADVANCED DRUG DELIVERY REVIEWS
- IL-23 and IL-17 in tuberculosis
- (2008) Shabaana A. Khader et al. CYTOKINE
- Virus-sized vaccine delivery systems
- (2008) J SCHEERLINCK et al. DRUG DISCOVERY TODAY
- Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery
- (2008) B. Sayın et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started